Andrew J. Murphy, EVP Research at REGENERON PHARMACEUTICALS, INC. (REGN), sold 28,914 shares at $620.64 ($18.1M) on 2020-07-13, disclosed to the SEC on 2020-07-15.
Open-market sale of $18.1M REGN by EVP Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $620.64 | 96 | $60K | 0.3% |
| 2 | $620.64 | 96 | $60K | 0.3% |
| 3 | $621.98 | 81 | $50K | 0.3% |
| 4 | $621.98 | 81 | $50K | 0.3% |
| 5 | $622.74 | 333 | $207K | 1.1% |
| 6 | $622.74 | 333 |
| $207K |
| 1.1% |
| 7 | $623.66 | 740 | $462K | 2.5% |
| 8 | $623.66 | 740 | $462K | 2.5% |
| 9 | $623.98 | 6,691 | $4.2M | 23.1% |
| 10 | $624.47 | 370 | $231K | 1.3% |
| 11 | $624.47 | 370 | $231K | 1.3% |
| 12 | $625.86 | 173 | $108K | 0.6% |
| 13 | $625.86 | 173 | $108K | 0.6% |
| 14 | $626.63 | 1,003 | $629K | 3.5% |
| 15 | $626.63 | 1,003 | $629K | 3.5% |
| 16 | $627.54 | 657 | $412K | 2.3% |
| 17 | $627.54 | 657 | $412K | 2.3% |
| 18 | $628.32 | 259 | $163K | 0.9% |
| 19 | $628.32 | 259 | $163K | 0.9% |
| 20 | $629.62 | 883 | $556K | 3.1% |
| 21 | $629.62 | 883 | $556K | 3.1% |
| 22 | $630.50 | 1,423 | $897K | 5.0% |
| 23 | $630.50 | 1,423 | $897K | 5.0% |
| 24 | $631.45 | 861 | $544K | 3.0% |
| 25 | $631.45 | 861 | $544K | 3.0% |
| 26 | $632.65 | 680 | $430K | 2.4% |
| 27 | $633.28 | 441 | $279K | 1.5% |
| 28 | $633.28 | 441 | $279K | 1.5% |
| 29 | $614.62 | 178 | $109K | 0.6% |
| 30 | $614.62 | 178 | $109K | 0.6% |
| 31 | $615.59 | 203 | $125K | 0.7% |
| 32 | $615.59 | 203 | $125K | 0.7% |
| 33 | $616.34 | 256 | $158K | 0.9% |
| 34 | $616.34 | 256 | $158K | 0.9% |
| 35 | $617.64 | 304 | $188K | 1.0% |
| 36 | $617.64 | 304 | $188K | 1.0% |
| 37 | $618.39 | 255 | $158K | 0.9% |
| 38 | $618.39 | 255 | $158K | 0.9% |
| 39 | $619.28 | 162 | $100K | 0.6% |
| 40 | $619.28 | 162 | $100K | 0.6% |
| 41 | $620.94 | 81 | $50K | 0.3% |
| 42 | $620.94 | 81 | $50K | 0.3% |
| 43 | $621.06 | 113 | $70K | 0.4% |
| 44 | $621.06 | 113 | $70K | 0.4% |
| 45 | $622.51 | 1 | $623 | 0.0% |
| 46 | $624.77 | 487 | $304K | 1.7% |
| 47 | $624.77 | 487 | $304K | 1.7% |
| 48 | $625.05 | 4 | $3K | 0.0% |
| 49 | $626.66 | 83 | $52K | 0.3% |
| 50 | $626.66 | 83 | $52K | 0.3% |
| 51 | $628.50 | 950 | $597K | 3.3% |
| 52 | $629.58 | 852 | $536K | 3.0% |
| 53 | $629.58 | 852 | $536K | 3.0% |
| Total | $626.11 avg | 28,914 | $18.1M | 100% |
| Filing → |
| REGN | SELL | 2024-03-15 | $11.0M | — | Filing → |
| REGN | SELL | 2023-12-06 | $10.6M | — | Filing → |
| REGN | SELL | 2023-11-15 | $10.3M | — | Filing → |